Companies Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals (ORIC): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Oric Pharmaceuticals, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $3,153,083FY2023
- $5,282,815FY2024
- $5,567,164FY2025
CEO total pay was $5,567,164 in fiscal 2025, up from $5,282,815 in fiscal 2024.
FY2025: salary $657,500 · bonus $0 · stock awards $826,000 · option awards $3,634,560
Executives and directors
Frequently asked questions
Who was the highest-paid executive at Oric Pharmaceuticals, Inc. in fiscal 2025?
As disclosed, Jacob Chacko (President, Chief Executive Officer and Director) was the highest-paid executive at Oric Pharmaceuticals, Inc. in fiscal 2025, with total compensation of $5,567,164.
How did shareholders vote on Oric Pharmaceuticals, Inc.'s executive compensation?
As disclosed, 98.6% of shareholders supported Oric Pharmaceuticals, Inc.'s executive compensation in the latest say-on-pay vote.
How much does Oric Pharmaceuticals, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Oric Pharmaceuticals, Inc. reported total board compensation of $310,000 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jacob Chacko | $657,500 | $0 | $826,000 | $3,634,560 | $434,000 | $0 | $15,104 | $5,567,164 |
| President, Chief Executive Officer and Director | ||||||||
| Pratik Multani | 513,333 | 0 | 280,840 | 1,226,664 | 246,500 | 0 | 15,104 | 2,282,441 |
| Chief Medical Officer | ||||||||
| Dominic Piscitelli | 482,917 | 0 | 280,840 | 1,226,664 | 231,900 | 0 | 15,104 | 2,237,425 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Jacob Chacko | $5,567,164 | $5,282,815 | $3,153,083 | ↑ +284,349 |
| Pratik Multani | 2,282,441 | 2,233,391 | 1,510,299 | ↑ +49,050 |
| Dominic Piscitelli | 2,237,425 | 2,181,959 | 1,449,821 | ↑ +55,466 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company aims to provide competitive and fair compensation to executive officers, ensuring it is commensurate with their duties, contributions, and market data. The compensation structure is designed to attract and retain senior-level employees by aligning rewards with company results and individual goal achievement.
| CEO STI target (% of salary) | 55% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Jacob Chacko | PSU | — | — | — | — | — | $826,000 |
| Jacob Chacko | OPTION | — | — | — | — | — | 3,634,560 |
| Dominic Piscitelli | PSU | — | — | — | — | — | 280,840 |
| Dominic Piscitelli | OPTION | — | — | — | — | — | 1,226,664 |
| Pratik Multani | PSU | — | — | — | — | — | 280,840 |
| Pratik Multani | OPTION | — | — | — | — | — | 1,226,664 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Jacob Chacko | $0 | $826,000 | $3,634,560 | 18.5% |
| Dominic Piscitelli | 0 | 280,840 | 1,226,664 | 18.6% |
| Pratik Multani | 0 | 280,840 | 1,226,664 | 18.6% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Dominic Piscitelli | RSU | 10,000 | — | $81,800 |
| Pratik Multani | RSU | 10,000 | — | 81,800 |
| Dominic Piscitelli | RSU | 22,667 | — | 185,416 |
| Pratik Multani | RSU | 22,667 | — | 185,416 |
| Jacob Chacko | RSU | 28,334 | — | 231,772 |
| Dominic Piscitelli | Option | 28,985 | 4.36 | — |
| Pratik Multani | Option | 28,985 | 4.36 | — |
| Dominic Piscitelli | Option | 42,292 | 6 | — |
| Pratik Multani | Option | 42,292 | 6 | — |
| Jacob Chacko | RSU | 66,667 | — | 545,336 |
| Jacob Chacko | Option | 84,584 | 4.36 | — |
| Dominic Piscitelli | Option | 93,750 | 9.14 | — |
| Pratik Multani | Option | 93,750 | 9.14 | — |
| Jacob Chacko | Option | 116,667 | 6 | — |
| Dominic Piscitelli | Option | 202,500 | 8.26 | — |
| Pratik Multani | Option | 202,500 | 8.26 | — |
| Jacob Chacko | Option | 265,625 | 9.14 | — |
| Jacob Chacko | Option | 600,000 | 8.26 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Richard Heyman, Ph.DIndependent · Board Chair · Compensation (Chair) · Partial-year service | $100,000 | $0 | $206,021 | $0 | $0 | $306,021 |
| Mardi C. DierIndependent · Audit (Chair) | 60,000 | 0 | 206,021 | 0 | 0 | 266,021 |
| Steven L. HoerterIndependent · Audit · Compensation | 52,500 | 0 | 206,021 | 0 | 0 | 258,521 |
| Angie You, Ph.DIndependent · Audit · Partial-year service | 52,500 | 0 | 206,021 | 0 | 0 | 258,521 |
| Lori Kunkel, M.DIndependent · Compensation | 45,000 | 0 | 206,021 | 0 | 0 | 251,021 |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 7,500 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $310,000 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $310,000 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Oric Pharmaceuticals as a peer
Companies that benchmark against ORIC
5 companies name ORIC as a compensation peer
The list of companies that name ORIC as a peer is temporarily unavailable — recheck shortly.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Oric Pharmaceuticals, Inc. | 2025 | Jacob Chacko | $657,500 | $826,000 | $3,634,560 | $434,000 | $5,567,164 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-18 | 88,453,809 | 1,250,074 | 2,373 | 98.6% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-18 | 98.6%a |
a. Approved under the standard stated in the filing — “As a result, abstentions will be counted for purposes of determining the presence or absence of a quorum and will also count as votes against a proposal in cases where approval of the proposal requires the affirmative vote of a majority of the voting power of the shares present in person (virtually) or represented by proxy at the Annual Meeting and entitled to vote on the subject matter ( e.g.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Richard A. Heyman | Director | 2026-07-06 | D | 300 | $12 | $3,600 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 7,000 | 12 | 84,140 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | A | 3,500 | 2 | 5,600 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 6,100 | 12 | 73,322 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 3,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | A | 25,000 | 6 | 150,000 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | A | 52,000 | 4 | 226,720 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | D | 25,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | D | 77,000 | 14 | 1,053,814 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | D | 52,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-09-24 | — | 600 | — | — | 1 insider, 1 accrual row | ||
| Dominic Piscitelli | Chief Financial Officer | 2026-09-24 | D | 500 | 14 | 6,753 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-24 | D | 100 | 14 | 1,350 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-24 | A | 600 | 4 | 2,616 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-28 | D | 13,400 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-28 | D | 13,400 | 14 | 181,258 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-28 | A | 13,400 | 4 | 58,424 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-10-01 | D | 3,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-10-01 | D | 3,200 | 13 | 41,325 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-10-01 | D | 3,500 | 13 | 45,199 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-10-01 | A | 3,500 | 2 | 5,600 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-10-20 | D | 14,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-10-20 | D | 14,000 | 14 | 189,391 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-10-20 | A | 14,000 | 4 | 61,040 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 24 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Richard A. Heyman | Director | 2026-07-06 | D | 300 | $12 | $3,600 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 7,000 | 12 | 84,140 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | A | 3,500 | 2 | 5,600 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 6,100 | 12 | 73,322 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 3,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | A | 25,000 | 6 | 150,000 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | A | 52,000 | 4 | 226,720 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | D | 25,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | D | 77,000 | 14 | 1,053,814 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-08-26 | D | 52,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-24 | D | 600 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-24 | D | 500 | 14 | 6,753 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-24 | D | 100 | 14 | 1,350 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-24 | A | 600 | 4 | 2,616 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-28 | D | 13,400 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-28 | D | 13,400 | 14 | 181,258 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-09-28 | A | 13,400 | 4 | 58,424 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-10-01 | D | 3,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-10-01 | D | 3,200 | 13 | 41,325 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-10-01 | D | 3,500 | 13 | 45,199 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-10-01 | A | 3,500 | 2 | 5,600 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-10-20 | D | 14,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-10-20 | D | 14,000 | 14 | 189,391 | Common | Form 4 ↗ |
| Dominic Piscitelli | Chief Financial Officer | 2026-10-20 | A | 14,000 | 4 | 61,040 | Common | Form 4 ↗ |
Sources (44 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Jacob Chacko. DEF 14A, filed 2026-04-28. Section “Summary Compensation Table” · page 42. As printed: 5,567,164. View filing ↗
- Section 01, Pratik Multani. DEF 14A, filed 2026-04-28. Section “Summary Compensation Table”. As printed: 2,282,441. View filing ↗
- Section 01, Dominic Piscitelli. DEF 14A, filed 2026-04-28. Section “Summary Compensation Table”. As printed: 2,237,425. View filing ↗
- Section 03, Jacob Chacko PSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Jacob Chacko OPTION. DEF 14A, filed 2026-04-28. Section “Summary Compensation Table” · grants of plan-based awards table. View filing ↗
- Section 03, Dominic Piscitelli PSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Dominic Piscitelli OPTION. DEF 14A, filed 2026-04-28. Section “Summary Compensation Table” · grants of plan-based awards table. View filing ↗
- Section 03, Pratik Multani PSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Pratik Multani OPTION. DEF 14A, filed 2026-04-28. Section “Summary Compensation Table” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. 10-K, filed 2026-02-23. Section “CEO Pay Ratio”. As printed: —. View filing ↗
- Section 08, Richard Heyman, Ph.D. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 306,021. View filing ↗
- Section 08, Mardi C. Dier. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 266,021. View filing ↗
- Section 08, Steven L. Hoerter. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 258,521. View filing ↗
- Section 08, Angie You, Ph.D. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 258,521. View filing ↗
- Section 08, Lori Kunkel, M.D. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 251,021. View filing ↗
- Section 02, Richard A. Heyman 2026-07-06. Form 4, filed 2026-07-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard A. Heyman 2026-07-24. Form 4, filed 2026-07-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard A. Heyman 2026-07-24. Form 4, filed 2026-07-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard A. Heyman 2026-07-24. Form 4, filed 2026-07-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard A. Heyman 2026-07-24. Form 4, filed 2026-07-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-08-26. Form 4, filed 2026-08-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-08-26. Form 4, filed 2026-08-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-08-26. Form 4, filed 2026-08-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-08-26. Form 4, filed 2026-08-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-08-26. Form 4, filed 2026-08-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-09-24. Form 4, filed 2026-09-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-09-24. Form 4, filed 2026-09-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-09-24. Form 4, filed 2026-09-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-09-24. Form 4, filed 2026-09-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-09-28. Form 4, filed 2026-09-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-09-28. Form 4, filed 2026-09-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-09-28. Form 4, filed 2026-09-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard A. Heyman 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard A. Heyman 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard A. Heyman 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard A. Heyman 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-10-20. Form 4, filed 2026-10-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-10-20. Form 4, filed 2026-10-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic Piscitelli 2026-10-20. Form 4, filed 2026-10-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-22. Item 5.07 · say-on-pay result. As reported: 98.6% (votes for as printed: 88,453,809). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 310,000 + equity 0 + all other 0 = 310,000, summed across the director compensation table rows.
- Oric Pharmaceuticals, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Oric Pharmaceuticals, Inc.'s own proxy. As printed: 5,567,164. View filing ↗